Considering the crucial role of EGF signaling in OX40 protumor effects in tumor ECs, we hypothesized that EGF signaling inhibitors would disrupt the adverse protumor effects of OX40 in ECs. This evidence concerns the gene TNFRSF4 and neoplasm.